Intronix Technologies Corp., based on Ontario, Canada, has announced its Myoguide needle electromyographic-guided injection system has received FDA 510(k) clearance, according to a news release.
The Myoguide system is designed to amplify EMG signals from muscle and provide audio feedback to assist clinicians in locating areas of muscle activity, according to the company. Treatment delivery can be in the form of neuromodulator injections to inserting a dry needle electrode.
Applications include pain management, spasticity and cosmetics.
The Myoguide system has already been in clinical use in Europe and Canada.
Related Articles on FDA Clearances:
Cytori Therapeutics Receives FDA Clearance for New Version of Puregraft System
Anulex Technologies Receives FDA Clearance for Additional Indications of fiXate Tissue Band
Spacelabs Healthcare Receives FDA 510(k) Clearance for New Anesthesia Delivery System